Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-03

AUTHORS

David A. Reardon, Annick Desjardins, Katherine B. Peters, Sridharan Gururangan, John H. Sampson, Roger E. McLendon, James E. Herndon, Anuradha Bulusu, Stevie Threatt, Allan H. Friedman, James J. Vredenburgh, Henry S. Friedman

ABSTRACT

We evaluated the efficacy of carboplatin, irinotecan, and bevacizumab among bevacizumab-naïve, recurrent glioblastoma (GBM) patients in a phase 2, open-label, single arm trial. Forty eligible patients received carboplatin (area under the plasma curve [AUC] 4 mg/ml-min) on day one, while bevacizumab (10 mg/kg) and irinotecan (340 mg/m(2) for patients on CYP3A-enzyme-inducing anti-epileptics [EIAEDs] and 125 mg/m(2) for patients not on EIAEDs) were administered on days 1 and 14 of every 28-day cycle. Patients were evaluated after each of the first two cycles and then after every other cycle. Treatment continued until progressive disease, unacceptable toxicity, non-compliance, or voluntary withdrawal. The primary endpoint was progression-free survival at 6 months (PFS-6) and secondary endpoints included safety and median overall survival (OS). All patients had progression after standard therapy. The median age was 51 years. Sixteen patients (40%) had a KPS of 90-100, while 27 (68%) were at first progression. The median time from original diagnosis was 11.4 months. The PFS-6 rate was 46.5% (95% CI: 30.4, 61.0%) and the median OS was 8.3 months [95% confidence interval (CI): 5.9, and 10.7 months]. Grade 4 events were primarily hematologic and included neutropenia and thrombocytopenia in 20 and 10%, respectively. The most common grade 3 events were neutropenia, thrombocytopenia, fatigue, and infection in 25, 20, 13, and 10%, respectively. Eleven patients (28%) discontinued study therapy due to toxicity and 17 patients (43%) required dose modification. One patient died due to treatment-related intestinal perforation. The addition of carboplatin and irinotecan to bevacizumab significantly increases toxicity but does not improve anti-tumor activity to that achieved historically with single-agent bevacizumab among bevacizumab-naïve, recurrent GBM patients. (ClinicalTrials.gov number NCT00953121). More... »

PAGES

155-164

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-011-0722-2

DOI

http://dx.doi.org/10.1007/s11060-011-0722-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1033962632

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21986722


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bevacizumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Camptothecin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carboplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA", 
            "Departments of Pediatrics, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reardon", 
        "givenName": "David A.", 
        "id": "sg:person.01334047606.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334047606.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Medicine, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Desjardins", 
        "givenName": "Annick", 
        "id": "sg:person.0701277507.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701277507.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Medicine, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peters", 
        "givenName": "Katherine B.", 
        "id": "sg:person.0744714665.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744714665.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA", 
            "Departments of Pediatrics, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gururangan", 
        "givenName": "Sridharan", 
        "id": "sg:person.010643343507.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010643343507.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sampson", 
        "givenName": "John H.", 
        "id": "sg:person.01127256465.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127256465.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Pathology, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McLendon", 
        "givenName": "Roger E.", 
        "id": "sg:person.016522551017.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016522551017.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Cancer Center Biostatistics, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Herndon", 
        "givenName": "James E.", 
        "id": "sg:person.01175371665.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175371665.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Cancer Center Biostatistics, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bulusu", 
        "givenName": "Anuradha", 
        "id": "sg:person.0620074352.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620074352.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Threatt", 
        "givenName": "Stevie", 
        "id": "sg:person.01311712043.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311712043.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Friedman", 
        "givenName": "Allan H.", 
        "id": "sg:person.01167656444.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167656444.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Medicine, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vredenburgh", 
        "givenName": "James J.", 
        "id": "sg:person.013241345417.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013241345417.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Departments of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA", 
            "Departments of Pediatrics, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Friedman", 
        "givenName": "Henry S.", 
        "id": "sg:person.01333344755.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333344755.48"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ccr.2006.11.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000989893"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-04-0074", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001828073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003700365", 
          "https://doi.org/10.1038/nm988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003700365", 
          "https://doi.org/10.1038/nm988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-2309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004441322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa061884", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008302687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.12.2440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008387745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605412", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008522472", 
          "https://doi.org/10.1038/sj.bjc.6605412"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605412", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008522472", 
          "https://doi.org/10.1038/sj.bjc.6605412"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-008-9749-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008577769", 
          "https://doi.org/10.1007/s11060-008-9749-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25462", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009168434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.16.3055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010751135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2004.10.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011422924"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2009.01.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012366197"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26381", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013882923"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa032691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014051315"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/367576a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016282476", 
          "https://doi.org/10.1038/367576a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-07-0552", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016764031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2009.01.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020649367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa021491", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020803009"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nop019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020985392"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/359845a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021927273", 
          "https://doi.org/10.1038/359845a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1014480108", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021998450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-06-4102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022228675"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26188", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028514124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.9027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029960724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa072113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033842397"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2008.10.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038799886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1215/s1152851703000620", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039348078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nop027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039490111"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.19.8721", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042965400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35025220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043028620", 
          "https://doi.org/10.1038/35025220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35025220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043028620", 
          "https://doi.org/10.1038/35025220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.3541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043187529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1038/sj.neo.7900102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044092012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2009-0121", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044143381"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044464024", 
          "https://doi.org/10.1038/sj.bjc.6601005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044464024", 
          "https://doi.org/10.1038/sj.bjc.6601005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800050771", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046233897", 
          "https://doi.org/10.1007/s002800050771"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9440(10)63273-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052447468"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800050050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053271473", 
          "https://doi.org/10.1007/s002800050050"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1535-6108(04)00305-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054716181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-199612000-00016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060113521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1104819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062451171"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.10.088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181bc0184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181bc0184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181bc0184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1215/15228517-2006-025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064414261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1215/s1152851703000218", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064420607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/2530298", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069975829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.5.1516", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074460874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074712943", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074718621", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074718628", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075330701", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076577573", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1991.9.5.860", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077652304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nop063", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078148309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/noq099", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078202685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.7.1277", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078716995"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-03", 
    "datePublishedReg": "2012-03-01", 
    "description": "We evaluated the efficacy of carboplatin, irinotecan, and bevacizumab among bevacizumab-na\u00efve, recurrent glioblastoma (GBM) patients in a phase 2, open-label, single arm trial. Forty eligible patients received carboplatin (area under the plasma curve [AUC] 4 mg/ml-min) on day one, while bevacizumab (10 mg/kg) and irinotecan (340 mg/m(2) for patients on CYP3A-enzyme-inducing anti-epileptics [EIAEDs] and 125 mg/m(2) for patients not on EIAEDs) were administered on days 1 and 14 of every 28-day cycle. Patients were evaluated after each of the first two cycles and then after every other cycle. Treatment continued until progressive disease, unacceptable toxicity, non-compliance, or voluntary withdrawal. The primary endpoint was progression-free survival at 6 months (PFS-6) and secondary endpoints included safety and median overall survival (OS). All patients had progression after standard therapy. The median age was 51 years. Sixteen patients (40%) had a KPS of 90-100, while 27 (68%) were at first progression. The median time from original diagnosis was 11.4 months. The PFS-6 rate was 46.5% (95% CI: 30.4, 61.0%) and the median OS was 8.3 months [95% confidence interval (CI): 5.9, and 10.7 months]. Grade 4 events were primarily hematologic and included neutropenia and thrombocytopenia in 20 and 10%, respectively. The most common grade 3 events were neutropenia, thrombocytopenia, fatigue, and infection in 25, 20, 13, and 10%, respectively. Eleven patients (28%) discontinued study therapy due to toxicity and 17 patients (43%) required dose modification. One patient died due to treatment-related intestinal perforation. The addition of carboplatin and irinotecan to bevacizumab significantly increases toxicity but does not improve anti-tumor activity to that achieved historically with single-agent bevacizumab among bevacizumab-na\u00efve, recurrent GBM patients. (ClinicalTrials.gov number NCT00953121).", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-011-0722-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2441054", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2634129", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "107"
      }
    ], 
    "name": "Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab na\u00efve, recurrent glioblastoma", 
    "pagination": "155-164", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a1ca222caf24dd62335568e7739735baa0dec4f9fd8b2251901d9f743580ed40"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21986722"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-011-0722-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1033962632"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-011-0722-2", 
      "https://app.dimensions.ai/details/publication/pub.1033962632"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T20:51", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8684_00000533.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-011-0722-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-011-0722-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-011-0722-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-011-0722-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-011-0722-2'


 

This table displays all metadata directly associated to this object as RDF triples.

391 TRIPLES      21 PREDICATES      101 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-011-0722-2 schema:about N01f1ec2777074fe090f2ff3b0bfc260d
2 N06e0bd3fc75246ef95d2eca11d7d7610
3 N07af3cfe85794b27832ee27bb00d3599
4 N1f919622be584db1bf1518a913169a29
5 N24955409834d49b896e7a433117cce28
6 N48c3953670e442bfb31a3e6e7627b19d
7 N5e4b276936534aa0893d7a3b0f4504c7
8 N66cf59e00c664a35a4a4a2783ccf2b68
9 N75b8c833f7c44f29a1092583091ae809
10 N7767aafef0ed4a4489e9f08c850730e7
11 N77f7b61fbb1343e9adb758197441f3d3
12 N7d8a4f2d032a4973a360b6f9fd7bf351
13 N8d2b3e2cec9049d88acdd46c48879005
14 N8dff755740944001b630e5c715ee2b28
15 N90be831811154bd58c8bacd1a320f64e
16 Ncdc008785ad04e20ae2b3f28390d2f7f
17 Ne3a7845f5e0b4ba59778258d2612c46a
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author N50e55a65d51f4b019c18e11c65269462
21 schema:citation sg:pub.10.1007/s002800050050
22 sg:pub.10.1007/s002800050771
23 sg:pub.10.1007/s11060-008-9749-4
24 sg:pub.10.1038/35025220
25 sg:pub.10.1038/359845a0
26 sg:pub.10.1038/367576a0
27 sg:pub.10.1038/nm988
28 sg:pub.10.1038/sj.bjc.6601005
29 sg:pub.10.1038/sj.bjc.6605412
30 https://app.dimensions.ai/details/publication/pub.1074712943
31 https://app.dimensions.ai/details/publication/pub.1074718621
32 https://app.dimensions.ai/details/publication/pub.1074718628
33 https://app.dimensions.ai/details/publication/pub.1075330701
34 https://app.dimensions.ai/details/publication/pub.1076577573
35 https://doi.org/10.1002/cncr.25462
36 https://doi.org/10.1002/cncr.26188
37 https://doi.org/10.1002/cncr.26381
38 https://doi.org/10.1016/j.ccr.2004.10.011
39 https://doi.org/10.1016/j.ccr.2006.11.021
40 https://doi.org/10.1016/j.ccr.2009.01.021
41 https://doi.org/10.1016/j.ccr.2009.01.027
42 https://doi.org/10.1016/j.ijrobp.2008.10.043
43 https://doi.org/10.1016/s0002-9440(10)63273-7
44 https://doi.org/10.1016/s1535-6108(04)00305-8
45 https://doi.org/10.1038/sj.neo.7900102
46 https://doi.org/10.1056/nejmoa021491
47 https://doi.org/10.1056/nejmoa032691
48 https://doi.org/10.1056/nejmoa061884
49 https://doi.org/10.1056/nejmoa072113
50 https://doi.org/10.1073/pnas.1014480108
51 https://doi.org/10.1093/neuonc/nop019
52 https://doi.org/10.1093/neuonc/nop027
53 https://doi.org/10.1093/neuonc/nop063
54 https://doi.org/10.1093/neuonc/noq099
55 https://doi.org/10.1097/00000421-199612000-00016
56 https://doi.org/10.1126/science.1104819
57 https://doi.org/10.1158/0008-5472.can-04-0074
58 https://doi.org/10.1158/0008-5472.can-06-4102
59 https://doi.org/10.1158/1078-0432.ccr-06-2309
60 https://doi.org/10.1158/1535-7163.mct-07-0552
61 https://doi.org/10.1200/jco.1990.8.7.1277
62 https://doi.org/10.1200/jco.1991.9.5.860
63 https://doi.org/10.1200/jco.1999.17.5.1516
64 https://doi.org/10.1200/jco.2002.10.088
65 https://doi.org/10.1200/jco.2007.12.2440
66 https://doi.org/10.1200/jco.2008.16.3055
67 https://doi.org/10.1200/jco.2008.19.8721
68 https://doi.org/10.1200/jco.2009.26.3541
69 https://doi.org/10.1200/jco.2009.26.9027
70 https://doi.org/10.1212/wnl.0b013e3181bc0184
71 https://doi.org/10.1215/15228517-2006-025
72 https://doi.org/10.1215/s1152851703000218
73 https://doi.org/10.1215/s1152851703000620
74 https://doi.org/10.1634/theoncologist.2009-0121
75 https://doi.org/10.2307/2530298
76 schema:datePublished 2012-03
77 schema:datePublishedReg 2012-03-01
78 schema:description We evaluated the efficacy of carboplatin, irinotecan, and bevacizumab among bevacizumab-naïve, recurrent glioblastoma (GBM) patients in a phase 2, open-label, single arm trial. Forty eligible patients received carboplatin (area under the plasma curve [AUC] 4 mg/ml-min) on day one, while bevacizumab (10 mg/kg) and irinotecan (340 mg/m(2) for patients on CYP3A-enzyme-inducing anti-epileptics [EIAEDs] and 125 mg/m(2) for patients not on EIAEDs) were administered on days 1 and 14 of every 28-day cycle. Patients were evaluated after each of the first two cycles and then after every other cycle. Treatment continued until progressive disease, unacceptable toxicity, non-compliance, or voluntary withdrawal. The primary endpoint was progression-free survival at 6 months (PFS-6) and secondary endpoints included safety and median overall survival (OS). All patients had progression after standard therapy. The median age was 51 years. Sixteen patients (40%) had a KPS of 90-100, while 27 (68%) were at first progression. The median time from original diagnosis was 11.4 months. The PFS-6 rate was 46.5% (95% CI: 30.4, 61.0%) and the median OS was 8.3 months [95% confidence interval (CI): 5.9, and 10.7 months]. Grade 4 events were primarily hematologic and included neutropenia and thrombocytopenia in 20 and 10%, respectively. The most common grade 3 events were neutropenia, thrombocytopenia, fatigue, and infection in 25, 20, 13, and 10%, respectively. Eleven patients (28%) discontinued study therapy due to toxicity and 17 patients (43%) required dose modification. One patient died due to treatment-related intestinal perforation. The addition of carboplatin and irinotecan to bevacizumab significantly increases toxicity but does not improve anti-tumor activity to that achieved historically with single-agent bevacizumab among bevacizumab-naïve, recurrent GBM patients. (ClinicalTrials.gov number NCT00953121).
79 schema:genre research_article
80 schema:inLanguage en
81 schema:isAccessibleForFree true
82 schema:isPartOf N5dbab443728e4c9ea21cda574c5a7a1f
83 Ned3f706370be418dba7ff3110e84e8f2
84 sg:journal.1094205
85 schema:name Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma
86 schema:pagination 155-164
87 schema:productId N0d734e81b7824486bec320dce8b100f6
88 N3b6f8d418ad34b2a899aa2babefd4caf
89 N9e38ef1e8dd14e39bd98d857665b20b7
90 Nab410b457f3b43c7b33ee1e7f90d413c
91 Nd1d05d05a0b845a981a3af4013724473
92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033962632
93 https://doi.org/10.1007/s11060-011-0722-2
94 schema:sdDatePublished 2019-04-10T20:51
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher N62e55955ba4a475d9472ddc93ddfa435
97 schema:url http://link.springer.com/10.1007%2Fs11060-011-0722-2
98 sgo:license sg:explorer/license/
99 sgo:sdDataset articles
100 rdf:type schema:ScholarlyArticle
101 N01f1ec2777074fe090f2ff3b0bfc260d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Carboplatin
103 rdf:type schema:DefinedTerm
104 N06e0bd3fc75246ef95d2eca11d7d7610 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Bevacizumab
106 rdf:type schema:DefinedTerm
107 N07af3cfe85794b27832ee27bb00d3599 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Treatment Outcome
109 rdf:type schema:DefinedTerm
110 N0d734e81b7824486bec320dce8b100f6 schema:name doi
111 schema:value 10.1007/s11060-011-0722-2
112 rdf:type schema:PropertyValue
113 N1f919622be584db1bf1518a913169a29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Camptothecin
115 rdf:type schema:DefinedTerm
116 N24955409834d49b896e7a433117cce28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Humans
118 rdf:type schema:DefinedTerm
119 N38f25b7c36e440dba72e5099b7b6147f rdf:first sg:person.013241345417.00
120 rdf:rest Nc6c1c7b7651947f3a3e9df245903709b
121 N3b6f8d418ad34b2a899aa2babefd4caf schema:name pubmed_id
122 schema:value 21986722
123 rdf:type schema:PropertyValue
124 N44f1d542590949909fbadc50768e696a rdf:first sg:person.0620074352.30
125 rdf:rest N74bd1f1248d241efa75d356b483b92e6
126 N48c3953670e442bfb31a3e6e7627b19d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Antibodies, Monoclonal, Humanized
128 rdf:type schema:DefinedTerm
129 N50e55a65d51f4b019c18e11c65269462 rdf:first sg:person.01334047606.77
130 rdf:rest N7fff42a6841a4216b9d0aa1c50c97f4c
131 N5dbab443728e4c9ea21cda574c5a7a1f schema:volumeNumber 107
132 rdf:type schema:PublicationVolume
133 N5e4b276936534aa0893d7a3b0f4504c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Male
135 rdf:type schema:DefinedTerm
136 N62e55955ba4a475d9472ddc93ddfa435 schema:name Springer Nature - SN SciGraph project
137 rdf:type schema:Organization
138 N66cf59e00c664a35a4a4a2783ccf2b68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Neoplasm Recurrence, Local
140 rdf:type schema:DefinedTerm
141 N730d11c4836e412aacbacdeef033e895 rdf:first sg:person.01127256465.77
142 rdf:rest Nb8755b1047684e4c9f35f78f2f0447dc
143 N74bd1f1248d241efa75d356b483b92e6 rdf:first sg:person.01311712043.25
144 rdf:rest Nf4da0fd79bc548f0a126beee800f67f1
145 N75b8c833f7c44f29a1092583091ae809 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Antineoplastic Combined Chemotherapy Protocols
147 rdf:type schema:DefinedTerm
148 N7767aafef0ed4a4489e9f08c850730e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Survival Rate
150 rdf:type schema:DefinedTerm
151 N77f7b61fbb1343e9adb758197441f3d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Aged
153 rdf:type schema:DefinedTerm
154 N7d8a4f2d032a4973a360b6f9fd7bf351 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Follow-Up Studies
156 rdf:type schema:DefinedTerm
157 N7fff42a6841a4216b9d0aa1c50c97f4c rdf:first sg:person.0701277507.35
158 rdf:rest Ndce31184afeb49b9a36bd346a98dc152
159 N8c7efadabdb24de28ceab004a0fc41a3 rdf:first sg:person.010643343507.68
160 rdf:rest N730d11c4836e412aacbacdeef033e895
161 N8d2b3e2cec9049d88acdd46c48879005 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Glioblastoma
163 rdf:type schema:DefinedTerm
164 N8dff755740944001b630e5c715ee2b28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Female
166 rdf:type schema:DefinedTerm
167 N90be831811154bd58c8bacd1a320f64e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Adult
169 rdf:type schema:DefinedTerm
170 N9e38ef1e8dd14e39bd98d857665b20b7 schema:name readcube_id
171 schema:value a1ca222caf24dd62335568e7739735baa0dec4f9fd8b2251901d9f743580ed40
172 rdf:type schema:PropertyValue
173 Nab410b457f3b43c7b33ee1e7f90d413c schema:name nlm_unique_id
174 schema:value 8309335
175 rdf:type schema:PropertyValue
176 Nb8755b1047684e4c9f35f78f2f0447dc rdf:first sg:person.016522551017.09
177 rdf:rest Nd7f13f9c7a5d405084023549b7f04baa
178 Nc6c1c7b7651947f3a3e9df245903709b rdf:first sg:person.01333344755.48
179 rdf:rest rdf:nil
180 Ncdc008785ad04e20ae2b3f28390d2f7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Middle Aged
182 rdf:type schema:DefinedTerm
183 Nd1d05d05a0b845a981a3af4013724473 schema:name dimensions_id
184 schema:value pub.1033962632
185 rdf:type schema:PropertyValue
186 Nd7f13f9c7a5d405084023549b7f04baa rdf:first sg:person.01175371665.07
187 rdf:rest N44f1d542590949909fbadc50768e696a
188 Ndce31184afeb49b9a36bd346a98dc152 rdf:first sg:person.0744714665.06
189 rdf:rest N8c7efadabdb24de28ceab004a0fc41a3
190 Ne3a7845f5e0b4ba59778258d2612c46a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Brain Neoplasms
192 rdf:type schema:DefinedTerm
193 Ned3f706370be418dba7ff3110e84e8f2 schema:issueNumber 1
194 rdf:type schema:PublicationIssue
195 Nf4da0fd79bc548f0a126beee800f67f1 rdf:first sg:person.01167656444.57
196 rdf:rest N38f25b7c36e440dba72e5099b7b6147f
197 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
198 schema:name Medical and Health Sciences
199 rdf:type schema:DefinedTerm
200 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
201 schema:name Clinical Sciences
202 rdf:type schema:DefinedTerm
203 sg:grant.2441054 http://pending.schema.org/fundedItem sg:pub.10.1007/s11060-011-0722-2
204 rdf:type schema:MonetaryGrant
205 sg:grant.2634129 http://pending.schema.org/fundedItem sg:pub.10.1007/s11060-011-0722-2
206 rdf:type schema:MonetaryGrant
207 sg:journal.1094205 schema:issn 0167-594X
208 1573-7373
209 schema:name Journal of Neuro-Oncology
210 rdf:type schema:Periodical
211 sg:person.010643343507.68 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
212 schema:familyName Gururangan
213 schema:givenName Sridharan
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010643343507.68
215 rdf:type schema:Person
216 sg:person.01127256465.77 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
217 schema:familyName Sampson
218 schema:givenName John H.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127256465.77
220 rdf:type schema:Person
221 sg:person.01167656444.57 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
222 schema:familyName Friedman
223 schema:givenName Allan H.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167656444.57
225 rdf:type schema:Person
226 sg:person.01175371665.07 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
227 schema:familyName Herndon
228 schema:givenName James E.
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175371665.07
230 rdf:type schema:Person
231 sg:person.01311712043.25 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
232 schema:familyName Threatt
233 schema:givenName Stevie
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311712043.25
235 rdf:type schema:Person
236 sg:person.013241345417.00 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
237 schema:familyName Vredenburgh
238 schema:givenName James J.
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013241345417.00
240 rdf:type schema:Person
241 sg:person.01333344755.48 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
242 schema:familyName Friedman
243 schema:givenName Henry S.
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333344755.48
245 rdf:type schema:Person
246 sg:person.01334047606.77 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
247 schema:familyName Reardon
248 schema:givenName David A.
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334047606.77
250 rdf:type schema:Person
251 sg:person.016522551017.09 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
252 schema:familyName McLendon
253 schema:givenName Roger E.
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016522551017.09
255 rdf:type schema:Person
256 sg:person.0620074352.30 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
257 schema:familyName Bulusu
258 schema:givenName Anuradha
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620074352.30
260 rdf:type schema:Person
261 sg:person.0701277507.35 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
262 schema:familyName Desjardins
263 schema:givenName Annick
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701277507.35
265 rdf:type schema:Person
266 sg:person.0744714665.06 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
267 schema:familyName Peters
268 schema:givenName Katherine B.
269 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744714665.06
270 rdf:type schema:Person
271 sg:pub.10.1007/s002800050050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053271473
272 https://doi.org/10.1007/s002800050050
273 rdf:type schema:CreativeWork
274 sg:pub.10.1007/s002800050771 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046233897
275 https://doi.org/10.1007/s002800050771
276 rdf:type schema:CreativeWork
277 sg:pub.10.1007/s11060-008-9749-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008577769
278 https://doi.org/10.1007/s11060-008-9749-4
279 rdf:type schema:CreativeWork
280 sg:pub.10.1038/35025220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043028620
281 https://doi.org/10.1038/35025220
282 rdf:type schema:CreativeWork
283 sg:pub.10.1038/359845a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021927273
284 https://doi.org/10.1038/359845a0
285 rdf:type schema:CreativeWork
286 sg:pub.10.1038/367576a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016282476
287 https://doi.org/10.1038/367576a0
288 rdf:type schema:CreativeWork
289 sg:pub.10.1038/nm988 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003700365
290 https://doi.org/10.1038/nm988
291 rdf:type schema:CreativeWork
292 sg:pub.10.1038/sj.bjc.6601005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044464024
293 https://doi.org/10.1038/sj.bjc.6601005
294 rdf:type schema:CreativeWork
295 sg:pub.10.1038/sj.bjc.6605412 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008522472
296 https://doi.org/10.1038/sj.bjc.6605412
297 rdf:type schema:CreativeWork
298 https://app.dimensions.ai/details/publication/pub.1074712943 schema:CreativeWork
299 https://app.dimensions.ai/details/publication/pub.1074718621 schema:CreativeWork
300 https://app.dimensions.ai/details/publication/pub.1074718628 schema:CreativeWork
301 https://app.dimensions.ai/details/publication/pub.1075330701 schema:CreativeWork
302 https://app.dimensions.ai/details/publication/pub.1076577573 schema:CreativeWork
303 https://doi.org/10.1002/cncr.25462 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009168434
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1002/cncr.26188 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028514124
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1002/cncr.26381 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013882923
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1016/j.ccr.2004.10.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011422924
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1016/j.ccr.2006.11.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000989893
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1016/j.ccr.2009.01.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012366197
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1016/j.ccr.2009.01.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020649367
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1016/j.ijrobp.2008.10.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038799886
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1016/s0002-9440(10)63273-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052447468
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1016/s1535-6108(04)00305-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054716181
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1038/sj.neo.7900102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044092012
324 rdf:type schema:CreativeWork
325 https://doi.org/10.1056/nejmoa021491 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020803009
326 rdf:type schema:CreativeWork
327 https://doi.org/10.1056/nejmoa032691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014051315
328 rdf:type schema:CreativeWork
329 https://doi.org/10.1056/nejmoa061884 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008302687
330 rdf:type schema:CreativeWork
331 https://doi.org/10.1056/nejmoa072113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033842397
332 rdf:type schema:CreativeWork
333 https://doi.org/10.1073/pnas.1014480108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021998450
334 rdf:type schema:CreativeWork
335 https://doi.org/10.1093/neuonc/nop019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020985392
336 rdf:type schema:CreativeWork
337 https://doi.org/10.1093/neuonc/nop027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039490111
338 rdf:type schema:CreativeWork
339 https://doi.org/10.1093/neuonc/nop063 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078148309
340 rdf:type schema:CreativeWork
341 https://doi.org/10.1093/neuonc/noq099 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078202685
342 rdf:type schema:CreativeWork
343 https://doi.org/10.1097/00000421-199612000-00016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060113521
344 rdf:type schema:CreativeWork
345 https://doi.org/10.1126/science.1104819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062451171
346 rdf:type schema:CreativeWork
347 https://doi.org/10.1158/0008-5472.can-04-0074 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001828073
348 rdf:type schema:CreativeWork
349 https://doi.org/10.1158/0008-5472.can-06-4102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022228675
350 rdf:type schema:CreativeWork
351 https://doi.org/10.1158/1078-0432.ccr-06-2309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004441322
352 rdf:type schema:CreativeWork
353 https://doi.org/10.1158/1535-7163.mct-07-0552 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016764031
354 rdf:type schema:CreativeWork
355 https://doi.org/10.1200/jco.1990.8.7.1277 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078716995
356 rdf:type schema:CreativeWork
357 https://doi.org/10.1200/jco.1991.9.5.860 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077652304
358 rdf:type schema:CreativeWork
359 https://doi.org/10.1200/jco.1999.17.5.1516 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074460874
360 rdf:type schema:CreativeWork
361 https://doi.org/10.1200/jco.2002.10.088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203153
362 rdf:type schema:CreativeWork
363 https://doi.org/10.1200/jco.2007.12.2440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008387745
364 rdf:type schema:CreativeWork
365 https://doi.org/10.1200/jco.2008.16.3055 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010751135
366 rdf:type schema:CreativeWork
367 https://doi.org/10.1200/jco.2008.19.8721 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042965400
368 rdf:type schema:CreativeWork
369 https://doi.org/10.1200/jco.2009.26.3541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043187529
370 rdf:type schema:CreativeWork
371 https://doi.org/10.1200/jco.2009.26.9027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029960724
372 rdf:type schema:CreativeWork
373 https://doi.org/10.1212/wnl.0b013e3181bc0184 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064354676
374 rdf:type schema:CreativeWork
375 https://doi.org/10.1215/15228517-2006-025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064414261
376 rdf:type schema:CreativeWork
377 https://doi.org/10.1215/s1152851703000218 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064420607
378 rdf:type schema:CreativeWork
379 https://doi.org/10.1215/s1152851703000620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039348078
380 rdf:type schema:CreativeWork
381 https://doi.org/10.1634/theoncologist.2009-0121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044143381
382 rdf:type schema:CreativeWork
383 https://doi.org/10.2307/2530298 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069975829
384 rdf:type schema:CreativeWork
385 https://www.grid.ac/institutes/grid.26009.3d schema:alternateName Duke University
386 schema:name Departments of Cancer Center Biostatistics, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA
387 Departments of Medicine, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA
388 Departments of Pathology, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA
389 Departments of Pediatrics, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA
390 Departments of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA
391 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...